The Xylazine bill aims to regulate the use of xylazine, a sedative commonly used in veterinary medicine but also misused in human populations as a recreational drug. The bill seeks to classify xylazine as a controlled substance due to its increasing prevalence in opioid overdoses and its potential for abuse. By placing restrictions on the distribution and handling of xylazine, the bill intends to address public health concerns related to its misuse and combat the opioid crisis.
2023-12-06: Filed
2023-12-19: Referred to Criminal Justice Subcommittee
2023-12-19: Referred to Regulatory Reform & Economic Development Subcommittee
2023-12-19: Referred to Judiciary Committee
2023-12-19: Now in Criminal Justice Subcommittee
2024-01-09: 1st Reading (Original Filed Version)
2024-03-08: Died in Criminal Justice Subcommittee
Contribute Your Insights: Add a Unique Perspective to Political Bills. Your Contribution will be Featured Below the Primary Bill, Ordered by Date Added.
No Reviews found ..